FDA Drug recall D-0662-2018

Testosterone 200 mg pellet packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702…

FDA Drug
Class II
terminated
Published 2018-04-25

On 2018-04-25 the FDA classified a Class II recall of Testosterone 200 mg pellet packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702… by Partell Specialty Pharmacy, citing lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Read the official FDA Drug notice

Agency	FDA Drug
Recall number	D-0662-2018
Classification	Class II
Status	terminated
Initiated	2018-03-22
Published	2018-04-25
Last updated	2026-09-13 11:52 UTC
Company	Partell Specialty Pharmacy
Distribution	NV

Product

Testosterone 200 mg pellet packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3

Reason

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Identifiers

code_info	Lot#: 20171128@9, BUD 05/27/2018; 20171201@74, BUD 05/30/2018; 20171211@68, BUD 06/09/2018; 20171218@51, BUD 06/16/2018… Lot#: 20171128@9, BUD 05/27/2018; 20171201@74, BUD 05/30/2018; 20171211@68, BUD 06/09/2018; 20171218@51, BUD 06/16/2018; 20171222@6, BUD 06/20/2018; 20180209@62, BUD 08/08/2018; 20180223@46, BUD 08/22/2018; 20180223@33, BUD 08/22/2018; 20180219@5, BUD 08/18/2018; 20171010@11, BUD 04/08/2018; 20171019@19, BUD 04/17/2018; 20171031@69, BUD 04/29/2018; 20171102@27, BUD 05/01/2018; 20171110@87, BUD 05/09/2018; 20171114@12, BUD 05/13/2018; 20171122@57, BUD 05/21/2018; 20180112@56, BUD 07/11/2018; 20180116@77, BUD 07/15/2018; 20180122@92, BUD 07/21/2018; 20180202@69, BUD 08/01/2018; 20180205@111, BUD 08/04/2018; 20180212@102, BUD 08/11/2018.

code_info

Lot#: 20171128@9, BUD 05/27/2018; 20171201@74, BUD 05/30/2018; 20171211@68, BUD 06/09/2018; 20171218@51, BUD 06/16/2018…

Lot#: 20171128@9, BUD 05/27/2018; 20171201@74, BUD 05/30/2018; 20171211@68, BUD 06/09/2018; 20171218@51, BUD 06/16/2018; 20171222@6, BUD 06/20/2018; 20180209@62, BUD 08/08/2018; 20180223@46, BUD 08/22/2018; 20180223@33, BUD 08/22/2018; 20180219@5, BUD 08/18/2018; 20171010@11, BUD 04/08/2018; 20171019@19, BUD 04/17/2018; 20171031@69, BUD 04/29/2018; 20171102@27, BUD 05/01/2018; 20171110@87, BUD 05/09/2018; 20171114@12, BUD 05/13/2018; 20171122@57, BUD 05/21/2018; 20180112@56, BUD 07/11/2018; 20180116@77, BUD 07/15/2018; 20180122@92, BUD 07/21/2018; 20180202@69, BUD 08/01/2018; 20180205@111, BUD 08/04/2018; 20180212@102, BUD 08/11/2018.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0662-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.